In this role, Mr Nicklas will oversee sales, marketing and managed care efforts for BTA’s products.
Prior to joining Biovail, Mr Nicklas was senior director of epilepsy marketing at Valeant Pharmaceuticals. Prior to that, he spent two years as group product director for Keppra at UCB Pharmaceuticals and eight years at AstraZeneca, where he was director of brand communications for Seroquel and director of managed markets for Nexium.